Replies to post #56393 on Muscle Pharm Corporation (MSLPQ)

[fellowshort1]

You may want to review how fully diluted EPS is calculated, (a function of weighted average shares outstanding for the full year.

Also you should read this: http://www.nysscpa.org/cpajournal/2004/804/perspectives/p6.htm

The above article brought up some things with employee base stock options and how they are shown on financial statements. You may be thinking in terms of the old accounting standards but they have since changed.

It goes into more detail about this sort of arrangement. Pay attention to this section:

"Although stock options clearly have some perceived value at the grant date, the exposure draft proposes measurement models that neither reflect the economic substance of every stock option transaction nor meet certain qualitative characteristics of accounting information under FASB Concept Statement 2, Qualitative Characteristics of Accounting Information. Specifically, the draft fails to demonstrate that the measurement models are representationally faithful and verifiable."

So the fact is that the shares should and will only be shown when the vested interest matures.

[fellowshort1]

I included the preferred shares conversion in my estimate.

[learning curve]

ID; in this case you are wrong. I confirmed by speaking with IR.
The issued are part of RSU grant NOT in addition.

O/S should be 9.4 roughly when all is said and done.

Does that mean she goes up tomorrow? I don't know....low volume, pps, MM's getting tempted to play?

IMO the RSU's would NOT been approved without major milestones being approved; all John B has said has taken place and is in tact.